Skip to main content
Erschienen in: Comparative Clinical Pathology 6/2011

01.12.2011 | Original Article

Immuno-histochemical staining expression of Ki67 protein in canine mammary gland carcinoma

verfasst von: Annahita Rezaie, Abbas Tavasoli, Mitra Mehrazma, Alireza Bahonar

Erschienen in: Comparative Clinical Pathology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Canine mammary gland carcinoma is ranked second after skin tumours in dogs in terms of frequency. Due to certain microscopic and biological features, canine tumours are very similar to human carcinomas, which may make the dog a good animal model. The objective of this study was to describe Ki67 protein expression properties using immuno-histochemical (IHC) staining using human antibody. In this study, 30 mammary gland tumour samples were studied. The histological diagnosis was made on the basis of the current World Health Organization classification for canine mammary tumours. Tumours were then graded histologically in accordance with the Elston and Ellis method for human breast tumours. IHC staining using MIB-1 antibody for detecting expression of Ki67 proteins (pKi67), was performed on canine mammary gland carcinoma tissue. Results from the semi-quantitative IHC assessment of pKi67 showed that 20% were negative, 20% were one plus, 36.5% were two plus, 23.3% were three plus. There was a significant difference between histological grade and pKi67 expression. This method would help the pathologist and clinician in determining a more accurate prognosis and treatment in canine mammary carcinoma and facilitate comparative studies of canine and human research.
Literatur
Zurück zum Zitat Abadie JJ, Amardeilh MA, Delverdier ME (1999) Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 215(11):1629–1634PubMed Abadie JJ, Amardeilh MA, Delverdier ME (1999) Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 215(11):1629–1634PubMed
Zurück zum Zitat Bostock DE, Moriarty J, Crocker J (1992) Correlation between histologic diagnosis mean nucleolar organiser region count and prognosis in canine mammary tumors. Vet Pathol 29:381–385PubMedCrossRef Bostock DE, Moriarty J, Crocker J (1992) Correlation between histologic diagnosis mean nucleolar organiser region count and prognosis in canine mammary tumors. Vet Pathol 29:381–385PubMedCrossRef
Zurück zum Zitat Bratulic M, Grabarevic Z, Artukovic B, Capak D (1996) Number of nucleoli and nucleolar organiser region per nucleus and nucleolus—prognostic value in canine mammary tumors. Vet Pathol 33:527–532PubMedCrossRef Bratulic M, Grabarevic Z, Artukovic B, Capak D (1996) Number of nucleoli and nucleolar organiser region per nucleus and nucleolus—prognostic value in canine mammary tumors. Vet Pathol 33:527–532PubMedCrossRef
Zurück zum Zitat Brown PJ, Rema A, Gartner F (2003) Immunohistochemical characteristics of canine aortic and carotid body tumours. J Vet Med A 50:140–144CrossRef Brown PJ, Rema A, Gartner F (2003) Immunohistochemical characteristics of canine aortic and carotid body tumours. J Vet Med A 50:140–144CrossRef
Zurück zum Zitat De Vico G, Agrimi U, Maiolino P (1994) Nucleolar size and mitotic index in basal cell carcinomas (BCC) and squamous cell carcinoma (SCC) of canine skin. J Vet Med A 41:76–79CrossRef De Vico G, Agrimi U, Maiolino P (1994) Nucleolar size and mitotic index in basal cell carcinomas (BCC) and squamous cell carcinoma (SCC) of canine skin. J Vet Med A 41:76–79CrossRef
Zurück zum Zitat Funakoshi Y, Nakayama H, Uetsuka K, Nishimura R, Sasaki N, Doi K (2000) Cellular proliferation and telomerase activity in canine mammary gland tumors. Vet Pathol 37:177–183PubMedCrossRef Funakoshi Y, Nakayama H, Uetsuka K, Nishimura R, Sasaki N, Doi K (2000) Cellular proliferation and telomerase activity in canine mammary gland tumors. Vet Pathol 37:177–183PubMedCrossRef
Zurück zum Zitat Geraldes M, Gartner F, Schmitt F (2000) Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours. Vet Rec 146:403–406PubMedCrossRef Geraldes M, Gartner F, Schmitt F (2000) Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours. Vet Rec 146:403–406PubMedCrossRef
Zurück zum Zitat Ishikawa K, Sakai H, Hosoi M, Yanai T, Masegi T (2006) Evaluation of cell proliferation in canine tumors by the bromodeoxyuridine labeling method, immunostaining of Ki-67 antigen and proliferating cell nuclear antigen. J Toxicol Pathol 19:123–127CrossRef Ishikawa K, Sakai H, Hosoi M, Yanai T, Masegi T (2006) Evaluation of cell proliferation in canine tumors by the bromodeoxyuridine labeling method, immunostaining of Ki-67 antigen and proliferating cell nuclear antigen. J Toxicol Pathol 19:123–127CrossRef
Zurück zum Zitat Labelle P, Kyles AE, Farver TB, De Cock HEV (2004) Indicators of malignancy of canine adrenocortical tumors: histopathology and proliferation index. Vet Pathol 41:490–497PubMedCrossRef Labelle P, Kyles AE, Farver TB, De Cock HEV (2004) Indicators of malignancy of canine adrenocortical tumors: histopathology and proliferation index. Vet Pathol 41:490–497PubMedCrossRef
Zurück zum Zitat Laprie C, Abadie J, Amardeilh MF, Net JLE, Lagadic M, Delverdier M (2001) MIB-1 immunoreactivity correlates with histologic behaviour in canine cutaneous melanoma. Vet Dermatol 12:139–147PubMedCrossRef Laprie C, Abadie J, Amardeilh MF, Net JLE, Lagadic M, Delverdier M (2001) MIB-1 immunoreactivity correlates with histologic behaviour in canine cutaneous melanoma. Vet Dermatol 12:139–147PubMedCrossRef
Zurück zum Zitat Lohr CR, Teifke JP, Failing K, Weiss E (1997) Characterization of the proliferation state in canine mammary tumours by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Vet Pathol 34:212–221PubMedCrossRef Lohr CR, Teifke JP, Failing K, Weiss E (1997) Characterization of the proliferation state in canine mammary tumours by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Vet Pathol 34:212–221PubMedCrossRef
Zurück zum Zitat Madewell BR (2001) Cellular proliferation in tumors: a review of methods, interpretation, and clinical applications. J Vet Intern Med 15:334–340PubMedCrossRef Madewell BR (2001) Cellular proliferation in tumors: a review of methods, interpretation, and clinical applications. J Vet Intern Med 15:334–340PubMedCrossRef
Zurück zum Zitat Maiolino P, Restucci B, Papparella S, Paciello O, De Vico G (2004) Correlation of nuclear morphometric features with animal and human world health organization international histological classifications of canine spontaneous seminomas. Vet Pathol 41:608–611PubMedCrossRef Maiolino P, Restucci B, Papparella S, Paciello O, De Vico G (2004) Correlation of nuclear morphometric features with animal and human world health organization international histological classifications of canine spontaneous seminomas. Vet Pathol 41:608–611PubMedCrossRef
Zurück zum Zitat Millanta F, Fratini F, Corazza M, Castagnaro M, Zappulli V, Poli A (2002a) Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour. Res Vet Sci 73:45–51CrossRef Millanta F, Fratini F, Corazza M, Castagnaro M, Zappulli V, Poli A (2002a) Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour. Res Vet Sci 73:45–51CrossRef
Zurück zum Zitat Millanta F, Lazzeri G, Mazzei M, Vannozzi I, Poli A (2002b) MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis. Vet Pathol 39:120–126CrossRef Millanta F, Lazzeri G, Mazzei M, Vannozzi I, Poli A (2002b) MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis. Vet Pathol 39:120–126CrossRef
Zurück zum Zitat Misdorp W (2002) Tumours of the mammary gland. In: Meuten DJ (ed) Tumours in domestic animals, 4th edn. Blackwell, Iowa, pp 575–606CrossRef Misdorp W (2002) Tumours of the mammary gland. In: Meuten DJ (ed) Tumours in domestic animals, 4th edn. Blackwell, Iowa, pp 575–606CrossRef
Zurück zum Zitat Misdorp W, Else RW, Hellmén E, Lipscomb TP (1999) Histological classification of mammary tumors of the dog and cat. In: Shulman FI (ed) World Health Organization international histological classification of tumors of domestic animals, vol 7, 2nd edn. Armed Forces Institute of Pathology, Washington, pp 1–59 Misdorp W, Else RW, Hellmén E, Lipscomb TP (1999) Histological classification of mammary tumors of the dog and cat. In: Shulman FI (ed) World Health Organization international histological classification of tumors of domestic animals, vol 7, 2nd edn. Armed Forces Institute of Pathology, Washington, pp 1–59
Zurück zum Zitat Mukaratirwa S (2005) Prognostic and predictive markers in canine tumours: rationale and relevance. A review. Vet Q 27(2):52–64PubMedCrossRef Mukaratirwa S (2005) Prognostic and predictive markers in canine tumours: rationale and relevance. A review. Vet Q 27(2):52–64PubMedCrossRef
Zurück zum Zitat Nowak M, Madej JA, Dziegiel P (2005) Correlation in the expression of her2 receptor and Ki-67 antigen in mammary adenocarcinoma in bitches. Bull Vet Inst Pulawy 49:337–342 Nowak M, Madej JA, Dziegiel P (2005) Correlation in the expression of her2 receptor and Ki-67 antigen in mammary adenocarcinoma in bitches. Bull Vet Inst Pulawy 49:337–342
Zurück zum Zitat Ohta G, Sakai H, Kachi S, Hirata A, Yonemaru K, Kitajima A, Yanai T, Masegi T (2004) Assessment of proliferative potentials of canine osteosarcomas and chondrosarcomas by MIB-1 immunohistochemistry and bromodeoxyuridine incorporation. J Comp Path 131:18–27PubMedCrossRef Ohta G, Sakai H, Kachi S, Hirata A, Yonemaru K, Kitajima A, Yanai T, Masegi T (2004) Assessment of proliferative potentials of canine osteosarcomas and chondrosarcomas by MIB-1 immunohistochemistry and bromodeoxyuridine incorporation. J Comp Path 131:18–27PubMedCrossRef
Zurück zum Zitat Pena LL, Nieto AI, Rerez-Alenza D, Cuesta P, Castano M (1998) Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumours: relationship to clinical and pathologic variables. J Vet Diagn Investig 10:237–246CrossRef Pena LL, Nieto AI, Rerez-Alenza D, Cuesta P, Castano M (1998) Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumours: relationship to clinical and pathologic variables. J Vet Diagn Investig 10:237–246CrossRef
Zurück zum Zitat Rezaie A, Tavasoli A, Bahonar A, Mehrazma M (2009) Grading in canine mammary carcinoma. J Biol Sci 9(4):333–338CrossRef Rezaie A, Tavasoli A, Bahonar A, Mehrazma M (2009) Grading in canine mammary carcinoma. J Biol Sci 9(4):333–338CrossRef
Zurück zum Zitat Sakai H, Noda A, Shirai N, Iidaka TT, Yanai T, Masegi T (2002) Proliferative activity of canine mast cell tumours evaluated by Bromodeoxyuridine Incorporation and Ki-67 expression. J Comp Pathol 127:233–238PubMedCrossRef Sakai H, Noda A, Shirai N, Iidaka TT, Yanai T, Masegi T (2002) Proliferative activity of canine mast cell tumours evaluated by Bromodeoxyuridine Incorporation and Ki-67 expression. J Comp Pathol 127:233–238PubMedCrossRef
Zurück zum Zitat Sarli G, Benazzi C, Preziosi R, Marcato PS (1994) Proliferative activity assessed by Anti-PCNA and Ki67 monoclonal antibodies in canine testicular tumors. J Comp Pathol 110:357–368PubMedCrossRef Sarli G, Benazzi C, Preziosi R, Marcato PS (1994) Proliferative activity assessed by Anti-PCNA and Ki67 monoclonal antibodies in canine testicular tumors. J Comp Pathol 110:357–368PubMedCrossRef
Zurück zum Zitat Sarli G, Preziosi R, Benazzi C, Castellani G, Marcato PS (2002) Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. J Vet Diagn Investig 14:25–34CrossRef Sarli G, Preziosi R, Benazzi C, Castellani G, Marcato PS (2002) Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. J Vet Diagn Investig 14:25–34CrossRef
Zurück zum Zitat Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311–322PubMedCrossRef Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311–322PubMedCrossRef
Zurück zum Zitat Zuccari DAPC, Santana AE, Cury PM et al (2004) Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasm. Vet Clin Pathol 33(1):23–28PubMedCrossRef Zuccari DAPC, Santana AE, Cury PM et al (2004) Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasm. Vet Clin Pathol 33(1):23–28PubMedCrossRef
Metadaten
Titel
Immuno-histochemical staining expression of Ki67 protein in canine mammary gland carcinoma
verfasst von
Annahita Rezaie
Abbas Tavasoli
Mitra Mehrazma
Alireza Bahonar
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Comparative Clinical Pathology / Ausgabe 6/2011
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-010-1032-3

Weitere Artikel der Ausgabe 6/2011

Comparative Clinical Pathology 6/2011 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …